Description
Product Description:
Nindanix is adumbrated for the analysis of locally advanced, metastatic or locally alternate non-small corpuscle lung blight (NSCLC) adenocarcinoma blazon in aggregate with docetaxel for the analysis of developed patients afterwards the abortion of first-line chemotherapy.
Product Features:
Product Name Nindanix
Generic Name Nintedanib
Formulation Capsule
Available Pack Size 80 & 50 Capsule
Available Strength 100 mg
Registrations Available
Reviews
There are no reviews yet.